Trademark applications and grants for Biogen Ma Inc. Biogen Ma Inc has 97 trademark applications. The latest application filed is for "a symbol or image mark"
Patent Application | Date |
---|---|
USE OF CATION-EXCHANGE CHROMATOGRAPHY IN THE FLOW-THROUGH MODE TO ENRICH POST-TRANSLATIONAL MODIFICATIONS 20220306684 - 17/718116 Ng; Austen ;   et al. | 2022-09-29 |
TRANS-CYCLOOCTENE LABELED ANTISENSE OLIGONUCLEOTIDES, RADIO LABELED TETRAZINE AND METHODS 20220290140 - 17/636600 COOK; Brendon Ellery ;   et al. | 2022-09-15 |
METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN 20220280610 - 17/827282 DEYKIN; Aaron | 2022-09-08 |
COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY 20220280548 - 17/635363 McCampbell; Alexander | 2022-09-08 |
POTENCY ASSAYS FOR VIRAL VECTOR PRODUCTION 20220267798 - 17/632874 Feschenko; Marina ;   et al. | 2022-08-25 |
SEC | 0001810387 | Biogen MA Inc. of MASSACHUSETTS |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.